Validation and Suitability Assessment of Multiplex Mesoscale Discovery Immunogenicity Assay for Establishing Serological Signatures Using Vaccinated, Non-Vaccinated and Breakthrough SARS-CoV-2 Infected Cases.
Saved in:
| Title: | Validation and Suitability Assessment of Multiplex Mesoscale Discovery Immunogenicity Assay for Establishing Serological Signatures Using Vaccinated, Non-Vaccinated and Breakthrough SARS-CoV-2 Infected Cases. |
|---|---|
| Authors: | Shengule S; Clinical Bioanalytical Department, Serum Institute of India Pvt. Ltd., Pune 411028, India., Alai S; Clinical Bioanalytical Department, Serum Institute of India Pvt. Ltd., Pune 411028, India., Bhandare S; Clinical Bioanalytical Department, Serum Institute of India Pvt. Ltd., Pune 411028, India., Patil S; Clinical Bioanalytical Department, Serum Institute of India Pvt. Ltd., Pune 411028, India., Gautam M; Clinical Bioanalytical Department, Serum Institute of India Pvt. Ltd., Pune 411028, India., Mangaonkar B; Clinical Bioanalytical Department, Serum Institute of India Pvt. Ltd., Pune 411028, India., Gupta S; Clinical Bioanalytical Department, Serum Institute of India Pvt. Ltd., Pune 411028, India., Shaligram U; Clinical Bioanalytical Department, Serum Institute of India Pvt. Ltd., Pune 411028, India., Gairola S; Clinical Bioanalytical Department, Serum Institute of India Pvt. Ltd., Pune 411028, India. |
| Source: | Vaccines [Vaccines (Basel)] 2024 Apr 18; Vol. 12 (4). Date of Electronic Publication: 2024 Apr 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38675815 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Validation and Suitability Assessment of Multiplex Mesoscale Discovery Immunogenicity Assay for Establishing Serological Signatures Using Vaccinated, Non-Vaccinated and Breakthrough SARS-CoV-2 Infected Cases. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Shengule+S%22">Shengule S</searchLink>; Clinical Bioanalytical Department, Serum Institute of India Pvt. Ltd., Pune 411028, India.<br /><searchLink fieldCode="AU" term="%22Alai+S%22">Alai S</searchLink>; Clinical Bioanalytical Department, Serum Institute of India Pvt. Ltd., Pune 411028, India.<br /><searchLink fieldCode="AU" term="%22Bhandare+S%22">Bhandare S</searchLink>; Clinical Bioanalytical Department, Serum Institute of India Pvt. Ltd., Pune 411028, India.<br /><searchLink fieldCode="AU" term="%22Patil+S%22">Patil S</searchLink>; Clinical Bioanalytical Department, Serum Institute of India Pvt. Ltd., Pune 411028, India.<br /><searchLink fieldCode="AU" term="%22Gautam+M%22">Gautam M</searchLink>; Clinical Bioanalytical Department, Serum Institute of India Pvt. Ltd., Pune 411028, India.<br /><searchLink fieldCode="AU" term="%22Mangaonkar+B%22">Mangaonkar B</searchLink>; Clinical Bioanalytical Department, Serum Institute of India Pvt. Ltd., Pune 411028, India.<br /><searchLink fieldCode="AU" term="%22Gupta+S%22">Gupta S</searchLink>; Clinical Bioanalytical Department, Serum Institute of India Pvt. Ltd., Pune 411028, India.<br /><searchLink fieldCode="AU" term="%22Shaligram+U%22">Shaligram U</searchLink>; Clinical Bioanalytical Department, Serum Institute of India Pvt. Ltd., Pune 411028, India.<br /><searchLink fieldCode="AU" term="%22Gairola+S%22">Gairola S</searchLink>; Clinical Bioanalytical Department, Serum Institute of India Pvt. Ltd., Pune 411028, India. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101629355%22">Vaccines</searchLink> [Vaccines (Basel)] 2024 Apr 18; Vol. 12 (4). <i>Date of Electronic Publication: </i>2024 Apr 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI+AG%22">MDPI AG </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101629355 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2076-393X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222076393X%22">2076393X </searchLink><i>NLM ISO Abbreviation: </i>Vaccines (Basel) <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38675815 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/vaccines12040433 Languages: – Code: eng Text: English Titles: – TitleFull: Validation and Suitability Assessment of Multiplex Mesoscale Discovery Immunogenicity Assay for Establishing Serological Signatures Using Vaccinated, Non-Vaccinated and Breakthrough SARS-CoV-2 Infected Cases. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Shengule S – PersonEntity: Name: NameFull: Alai S – PersonEntity: Name: NameFull: Bhandare S – PersonEntity: Name: NameFull: Patil S – PersonEntity: Name: NameFull: Gautam M – PersonEntity: Name: NameFull: Mangaonkar B – PersonEntity: Name: NameFull: Gupta S – PersonEntity: Name: NameFull: Shaligram U – PersonEntity: Name: NameFull: Gairola S IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 04 Text: 2024 Apr 18 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 2076-393X Numbering: – Type: volume Value: 12 – Type: issue Value: 4 Titles: – TitleFull: Vaccines Type: main |
| ResultId | 1 |
